Immunosuppressive Tumor Microenvironment of Osteosarcoma
Aaron Taylor, Jianting Sheng, Patrick Kwok Shing Ng, Jeffrey M. Harder, Parveen Kumar, Ju Young Ahn, Yuliang Cao, Alissa M. Dzis, Nathaniel Jillette, Andrew Goodspeed, Avery Bodlak, Qian Wu, Michael S. Isakoff, Joshy George, Jessica Grassmann, Diane Luo, William F. Flynn, Elise T. Courtois, Paul Robson, Masanori Hayashi, Alini Trujillo-Paolillo, Antônio Sérgio Petrilli, Sílvia Regina Caminada de Toledo, Fabiola Balarezo, Adam D. Lindsay, Bang H. Hoang, Stephen T.C. Wong, Ching C. Lau
Abstract
Background/Objectives: Osteosarcoma is the most common malignant bone tumor in children, characterized by a high degree of genomic instability, resulting in copy number alterations and genomic rearrangements without disease-defining recurrent mutations. Clinical trials based on molecular characterization have failed to find new effective therapies or improve outcomes over the last 40 years. Methods: To better understand the immune microenvironment of osteosarcoma, we performed single-cell RNA sequencing on six tumor biopsy samples, combined with a previously published cohort of six samples. Additional osteosarcoma samples were profiled using spatial transcriptomics for the validation of discovered subtypes and to add spatial context. Results: Analysis revealed immunosuppressive cells, including myeloid-derived suppressor cells (MDSCs), regulatory and exhausted T cells, and LAMP3+ dendritic cells. Conclusions: Using cell–cell communication modeling, we identified robust interactions between MDSCs and other cells, leading to NF-κB upregulation and an immunosuppressive microenvironment, as well as interactions involving regulatory T cells and osteosarcoma cells that promoted tumor progression and a proangiogenic niche.